ArticleSAGE open medicine2024

Cost-effectiveness of l-glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar's healthcare perspective.

Ahmad M Adel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.